Predictive Oncology Inc. (NASDAQ:POAI) went down by -0.58% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Medical Instruments & Supplies giant went up by $1.72 to trade ended Wednesday trading at $1.73. This is down from the $1.73 price recorded on Tuesday’s trading session. Its performance from the start of the year has also been negative, with POAI down by -34.10% year-to-date.
Predictive Oncology Inc. (POAI) started the day trading at $1.71 and recorded an intraday high of $1.775. It also recorded an intraday low of $1.62 during Wednesday’s trading session. Predictive Oncology Inc. is a very active stock that recorded a trading volume that is less than -64.17% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 525113, which is less than -64.17 of the total average daily trading volume of 862.06K.
Predictive Oncology Inc. (NASDAQ:POAI) 2020 Performance Impressive
The increase in POAI’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of POAI currently stands at $8.50, which is higher than the current trading price of the stock by 79.76%. However, POAI’s current trading price is -37.6% lower than the 52-week low price of $1.25. In terms of trading volume, Predictive Oncology Inc. currently experienced healthy participation during the last trading session. 525113 shares of Predictive Oncology Inc. were traded on the stock exchange on Wednesday, which is less than -64.17% of the 862.06K average trading volume of the stock.
The performance of the stock has been positive over the past year. POAI’s performance over the past one year has seen it plunge by -71.09%, while the stock has gone down by -43.61% in the last six months. The quarterly performance of POAI currently stands at 25.09%, and it is up by 22.86% in the last month. The only negative figure was from the weekly performance, which currently reads -3.37%. At the time of writing POAI’s report, the company has a total market cap of $18.64M, making it one of the largest publicly-traded companies in the world.Predictive Oncology Inc. also has over 29 employees all over the world.
POAI Insider Activities
For Predictive Oncology Inc., insiders hold 3.20% of all company shares. The insider transactions over the past six months are up by 84.70%. During that period, insiders bought 1,583,481 shares in 2 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Predictive Oncology Inc. now hold 3.48M shares, which is over 9.05% of the total company stocks. Institutional investors currently hold a large chunk of the POAI shares, as they control 32.68% of the company’s total stock.
POAI Fundamental Analysis
For Predictive Oncology Inc., the stock’s diluted earnings per share (EPS) stands at -5.67. The stock’s EPS growth this year is 12.90%, 58.70% in the previous five years. In terms the average annual revenue of 58.70% over the past half a decade.
The Return on Investment (ROI) on Predictive Oncology Inc.’s stock currently stands at -141.50%. The gross margin of the company is 62.00%.
At the moment, Predictive Oncology Inc.’s Total Debt to Equity ratio stands at 0.57, and they have a long-term Debt to Equity ratio of 0.20.
POAI Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of POAI currently stands at 4.40%, while the SMA50 is 13.79%. The biggest one is the SMA200, which is currently reading -39.74% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 56.03.